Prognostic impact of MALs and potential immunotherapy targets in uveal melanoma
Abstract Uveal melanoma (UM) is the most common primary ocular malignancy in adults, and the 5‐year disease‐related mortality rate is 30%. MAL proteolipid family (MALs), including T‐cell differentiation protein (MAL), T‐cell differentiation protein 2 (MAL2), and T‐cell differentiation protein like (...
Saved in:
Main Authors: | Jing Yang (Author), Zhou Fu (Author), Qin Xiang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of ferroptosis as a promising candidate for metastatic uveal melanoma treatment and prognostication
by: Ellie Swords, et al.
Published: (2024) -
Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy
by: Yunyue Li, et al.
Published: (2023) -
Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma
by: Matthew Yen, et al.
Published: (2018) -
Amelanotic uveal melanoma in an African patient
by: Rita Pinto Proença, MD, MSc, et al.
Published: (2018) -
Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?
by: Thomas van den Bosch, et al.
Published: (2010)